NCT01807156 2016-04-22Phase II Trial of Tivozanib in Advanced Hepatocellular CancerEmory UniversityPhase 2 Terminated7 enrolled 6 charts
NCT01478594 2015-07-08A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line TherapyAVEO Pharmaceuticals, Inc.Phase 2 Completed265 enrolled 34 charts